KOZARICH JOHN W sold LGND

May 1, 2026 · Form 4 insider transaction

KOZARICH JOHN W sold 165 shares of Ligand Pharmaceuticals Incorporated at $231.87 per share, a transaction worth $38.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 13 days after the transaction.

Direction
Disposed (sell-side)
Shares
165
Price
$231.87
Total value
$38.3K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 1, 2026
Filing dateMay 14, 2026
Shares owned after42,007
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.; The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $231.1200 to $232.0700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR